SVP and General Counsel Nicole R. Hadas sold $61K of Akebia Therapeutics, Inc.

Sold$61,335

$8.70Price

7,050Shares

−3%Stake

What AKBA did after the filing

Prices for AKBA after this filing aren't in yet.

Traded Fri, Feb 28. Filed Mon, Mar 2, 2:28 PM ET, during the session. Not investment advice.